Advertisement

Pharmacy

Gilead Sciences has agreed to donate drugs to the federal government that reduce the risk of HIV transmission for up to 200,000 people a year, HHS Secretary Alex Azar announced May 9.  

Below are eight legal actions involving members of the drug supply chain, including pharmaceutical companies, pharmacy benefit managers, pharmacies, pharmacists and distributors, reported by Becker's Hospital Review in the last two weeks.

Advertisement

McKesson has renewed its distribution agreement with its largest client, CVS Health, the drug distributor announced during its earnings call May 9, according to Reuters.

A generic version of Gilead Sciences' HIV prevention drug, Truvada, will be available one year earlier than expected due to an agreement struck with Teva Pharmaceuticals a few years ago, the drugmaker announced May 8, according to CNBC.

Shire's hereditary angioedema drug Takhzyro tops GoodRx's list of the most expensive drugs approved in the U.S. last year, with a list price of $573,820 per year.

Advertisement